Skip to content

The randomized, controlled, multicenter clinical study of LBP for the treatment of abdominal cavity irrigation in colorectal cancer

The randomized, controlled, multicenter clinical study of LBP for the treatment of abdominal cavity irrigation in colorectal cancer

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014617
Enrollment
Unknown
Registered
2018-01-24
Start date
2018-01-25
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

The treatment group:LBP lavage
The control group:Surgery alone

Sponsors

Chinese Academy of Medical Sciences Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-75 years old, male or female; 2. Histopathological diagnosis of colorectal cancer; 3. untreated patients,Previously did not receive chemotherapy or radiotherapy; 4. Preoperative imaging examination clinical staging was T4 or N+; 5. Physical condition ECOG PS 0-1; 6. The colonoscopy of the lower margin of the tumor was 10 cm. 7. Preoperative radiographic examination (chest pelvic abdominal enhancement CT or MRI) did not identify distant viscera or peritoneal metastasis; 8. Laboratory tests meet the following criteria: Bone marrow function:Absolute count of blood neutrophil (ANC) =1.5×10^9/L; Platelet (PLT) =100×10^9/L; Hemoglobin (HB) =90g/L; Liver function:Serum total bilirubin (TBIL), direct bilirubin (DBIL) = upper limit of normal (ULN)×1.5, alanine aminotransferase (ALT), aspartate aminotransferase; Kidney function: Serum creatinine (Cr) =ULN; Endogenous creatinine clearance (Ccr) =55 ml/min (calculated using the Cockcroft-Gault formula); 9. Women of childbearing age need to take effective contraceptive measures; 10. Patients or their legal representatives volunteer and sign informed consent forms.

Exclusion criteria

Exclusion criteria: 1.Major surgery or surgical injuries have not been healed in the first four weeks of the group. 2.In the past five years, malignant tumors with other histologic sources have been developed, except for the treatment of carcinoma of the cervical carcinoma in situ and basal cell carcinoma or squamous carcinoma of the skin. 3.Serious cardiovascular disease, including medical treatment can not control of high blood pressure (BP 160/95 mmHg or higher), unstable angina, over the past six months history of myocardial infarction, congestive heart failure > NYHA class II, severe arrhythmia and pericardial effusion, etc.; 4.Preoperative blood glucose control during the week was higher than 11.2mmol / L; 5.Severe infection requires intravenous antibiotics, antifungal or antiviral therapy; 6.Suffering from mental illness, poor compliance; 7.Bleeding in the first four weeks of the group was greater than that of CTCAE 3. 8.The researchers did not believe that the case was suitable for the group.

Design outcomes

Primary

MeasureTime frame
Peritoneal transfer rate;

Secondary

MeasureTime frame
Safety;OS;RFS;No retroperitoneal recurrence;The proportion of patients receiving adjuvant chemotherapy after surgery was compared;Two groups of postoperative complications;

Contacts

Public ContactXiShan Wang and HaiTao Zhou

National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical college

zhouhaitao@cicams.ac.cn+86 13381167333

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026